The ubiquitin-proteasome pathway marks proteins for destruction by conjugating polyubiquitin chains, which are recognized and degraded by the 26S proteasome barrel complex. E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3 (ubiquitin ligase) enzymes form a relay; E3 ligases provide substrate specificity through recognition of degradation signals (degrons). The proteasome hydrolyzes proteins into peptides while recycling ubiquitin, enabling rapid removal of misfolded, short-lived regulatory, and damaged proteins.
Use degradation assays with in vitro ubiquitination extracts or cell-free systems; track protein half-lives in cells. Identify substrates by proteomic analysis of cells treated with proteasome inhibitors.
From your study of post-translational modifications, you know that proteins can be chemically altered after translation to change their function, localization, or stability. Ubiquitination is the modification that controls protein destruction — it is how cells tag proteins that have outlived their usefulness, become damaged, or need to be removed at a precise moment in the cell cycle.
Ubiquitin is a small, 76-amino-acid protein that gets covalently attached to target proteins through a three-enzyme cascade. The process begins with E1 (ubiquitin-activating enzyme), which uses ATP to activate ubiquitin and load it onto an E2 (ubiquitin-conjugating enzyme). The E2 then works with an E3 (ubiquitin ligase) to transfer ubiquitin onto a lysine residue of the target protein. There are only two E1 enzymes in humans, about 40 E2s, and over 600 E3 ligases — this funnel-shaped hierarchy means that substrate specificity comes almost entirely from the E3. Each E3 ligase recognizes specific degrons (degradation signals) on target proteins, which might be exposed by misfolding, phosphorylation, or other modifications. This is how the system achieves precision: different E3 ligases patrol for different categories of proteins that need removal.
A single ubiquitin attached to a protein (monoubiquitination) does not trigger degradation — it serves other signaling functions like directing proteins to endosomes. Degradation requires a polyubiquitin chain, specifically one built through lysine-48 (K48) linkages, where each ubiquitin's C-terminus attaches to the K48 residue of the previous ubiquitin. A chain of at least four K48-linked ubiquitins acts as the "destroy me" flag. The 26S proteasome — a barrel-shaped complex with a narrow central channel — recognizes this chain, unfolds the tagged protein using ATP-dependent motors, and threads it through the barrel where proteolytic active sites chop it into short peptides. The ubiquitin molecules are cleaved off by deubiquitinating enzymes (DUBs) at the proteasome entrance and recycled for reuse.
This system is not merely a garbage disposal — it is a precision timing mechanism. The cell cycle depends on it: cyclin proteins accumulate to drive each cell cycle phase, then are rapidly destroyed by ubiquitin-proteasome degradation to allow the next phase to begin. The anaphase-promoting complex (APC/C), an E3 ligase, tags cyclins and securin for destruction at exactly the right moment. Cancer drugs like bortezomib work by inhibiting the proteasome, causing toxic accumulation of proteins that would normally be cleared — illustrating how central this pathway is to cellular homeostasis.
No topics depend on this one yet.